Merck Serono Juorope Limited,   United Kingdom

Follicle stimulating agent

For the syringe handle:

Solution for subcutaneous administration of 22 μg / 0.5 ml, 33 μg / 0.75 ml, 66 μg / 1.5 ml.

For a new type of syringe:

A solution for subcutaneous administration was 22 μg / 0.5 ml, 33 μg / 0.75 ml, 66 μg / 1.5 ml.

Gonadotropin-releasing hormone analog.
Lyophilizate for the preparation of a solution for subcutaneous administration 0.25 mg.